Bilateral subtotal thyroidectomy vs the Dunhill procedure
- Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy 2015 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 642 participantsGRADE not reported
Glutamine‐supplemented nutrition showed no clear difference in long‐term mortality (closest to six month) compared with non‐supplemented nutrition (moderate certainty).
It is very uncertain whether summary of findings TIVA changes mortality At 30 days compared with inhalational maintenance of anaesthesia (very low certainty).
The intervention showed no clear difference in procedural mortality (high certainty).
It is very uncertain whether the intervention changes reported mortality, low risk of bias studies only (very low certainty).
Buffered showed no clear difference in mortality (in‐hospital death and 30‐day mortality) compared with non‐buffered crystalloid intravenous fluid (low certainty).
Remote ischaemic preconditioning (RIPC) showed no clear difference in perioperative mortality (within 1 month after operation) compared with no RIPC (moderate certainty).
Active cerebral oxygenation monitoring showed no clear difference in intraoperative mortality or postoperative mortality: Death ( compared with blinded cerebral oxygenation monitoring (low certainty).
It is very uncertain whether laparoscopic changes late overall mortality (after the first 30 postoperative days) compared with open surgery (very low certainty).
It is very uncertain whether the intervention changes postoperative mortality (very low certainty).
It is very uncertain whether the intervention changes postoperative mortality (very low certainty).
It is very uncertain whether the intervention changes postoperative mortality (very low certainty).
Glutamine‐supplemented nutrition showed no clear difference in short‐term mortality (within hospital stay or closest to one month) compared with non‐supplemented nutrition (low certainty).
It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).
It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).
The intervention probably leads to higher early mortality (90 days) (moderate certainty).